跳至主要内容
临床试验/EUCTR2011-002469-39-NL
EUCTR2011-002469-39-NL进行中(未招募)不适用

DIAbetes-PREvention Trial - DiaPreT

Isala Klinieken0 个研究点开始时间: 2011年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion criteria
  • •Patients admitted with coronairy artery disease (PCI or CABG in stable CAD, or post STEMI and post non-STEMI) (inclusion within 2 month after admission)
  • Age = 18 years
  • Elevated HbA1c levels (HbA1c > 5.8% or > 40 mmol/mol) on admission
  • Access to a computer with internet connection
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 39
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 39

排除标准

  • Exclusion criteria
  • Known diabetics, with or without anti-diabetic medication
  • Contra-indications for Metformine use as stated in the medication registration
  • Life Expectancy <1 yr
  • Physical limitations/restrictions for participation in exercise programme or exercise testing
  • Fasting plasma glucose = 7.0 mmol/l or HbA1c = 53

研究者

发起方
Isala Klinieken

相似试验